Boston Cost Of Revenue vs Depreciation And Amortization Analysis

BSX Stock

USD 74.65 0.10 0.13%

Boston Scientific financial indicator trend analysis is way more than just evaluating Boston Scientific Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Boston Scientific Corp is a good investment. Please check the relationship between Boston Scientific Cost Of Revenue and its Depreciation And Amortization accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

Cost Of Revenue vs Depreciation And Amortization

Cost Of Revenue vs Depreciation And Amortization Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Boston Scientific Corp Cost Of Revenue account and Depreciation And Amortization. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Boston Scientific's Cost Of Revenue and Depreciation And Amortization is 0.94. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Boston Scientific Corp, assuming nothing else is changed. The correlation between historical values of Boston Scientific's Cost Of Revenue and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Boston Scientific Corp are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Cost Of Revenue i.e., Boston Scientific's Cost Of Revenue and Depreciation And Amortization go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Boston Scientific Corp income statement and represents the costs associated with goods and services Boston Scientific provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Most indicators from Boston Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Boston Scientific Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

At this time, Boston Scientific's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 679.4 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.29 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	8.1B	8.7B	9.9B	10.4B
Total Revenue	11.9B	12.7B	14.2B	15.0B

Gross Profit Total Revenue

Boston Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Short Term Investments
Total Assets		0.96	0.82	0.73	0.97	0.99	0.94	0.5	0.89	0.62	1.0	0.67	0.62	0.94	0.63	0.74	0.93	0.13	0.63	0.77	0.77	0.83	0.1	0.59	0.71	0.78
Short Long Term Debt Total	0.96		0.86	0.8	0.91	0.93	0.99	0.46	0.86	0.61	0.96	0.77	0.61	0.91	0.58	0.76	0.87	0.14	0.6	0.82	0.67	0.85	0.23	0.59	0.68	0.85
Other Current Liab	0.82	0.86		0.91	0.74	0.82	0.86	0.28	0.85	0.48	0.81	0.84	0.48	0.86	0.54	0.56	0.78	0.39	0.55	0.72	0.63	0.73	0.34	0.5	0.65	0.86
Total Current Liabilities	0.73	0.8	0.91		0.64	0.73	0.83	0.19	0.76	0.27	0.72	0.93	0.27	0.84	0.52	0.43	0.73	0.58	0.5	0.67	0.58	0.63	0.67	0.53	0.61	0.89
Total Stockholder Equity	0.97	0.91	0.74	0.64		0.97	0.87	0.65	0.9	0.64	0.97	0.55	0.64	0.88	0.5	0.64	0.94	0.03	0.5	0.65	0.8	0.78	0.01	0.43	0.58	0.77
Property Plant And Equipment Net	0.99	0.93	0.82	0.73	0.97		0.91	0.5	0.93	0.58	0.98	0.66	0.58	0.95	0.59	0.67	0.97	0.11	0.58	0.71	0.84	0.79	0.08	0.53	0.69	0.78
Net Debt	0.94	0.99	0.86	0.83	0.87	0.91		0.41	0.83	0.46	0.94	0.82	0.47	0.93	0.59	0.73	0.87	0.19	0.6	0.82	0.67	0.79	0.32	0.64	0.68	0.84
Retained Earnings	0.5	0.46	0.28	0.19	0.65	0.5	0.41		0.59	0.45	0.5	0.04	0.45	0.3	-0.29	0.05	0.55	-0.41	-0.23	0.05	0.56	0.3	-0.13	-0.31	-0.18	0.57
Accounts Payable	0.89	0.86	0.85	0.76	0.9	0.93	0.83	0.59		0.55	0.89	0.65	0.56	0.89	0.38	0.49	0.94	0.08	0.41	0.58	0.81	0.7	0.12	0.3	0.53	0.85
Cash	0.62	0.61	0.48	0.27	0.64	0.58	0.46	0.45	0.55		0.59	0.18	1.0	0.39	0.3	0.59	0.45	-0.13	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Non Current Assets Total	1.0	0.96	0.81	0.72	0.97	0.98	0.94	0.5	0.89	0.59		0.67	0.59	0.94	0.63	0.74	0.93	0.13	0.62	0.77	0.76	0.81	0.11	0.6	0.7	0.77
Non Currrent Assets Other	0.67	0.77	0.84	0.93	0.55	0.66	0.82	0.04	0.65	0.18	0.67		0.18	0.81	0.58	0.49	0.66	0.58	0.57	0.7	0.46	0.6	0.64	0.61	0.66	0.77
Cash And Short Term Investments	0.62	0.61	0.48	0.27	0.64	0.58	0.47	0.45	0.56	1.0	0.59	0.18		0.39	0.3	0.59	0.45	-0.13	0.43	0.54	0.29	0.78	-0.26	0.17	0.41	0.48
Net Receivables	0.94	0.91	0.86	0.84	0.88	0.95	0.93	0.3	0.89	0.39	0.94	0.81	0.39		0.69	0.67	0.94	0.29	0.65	0.76	0.78	0.73	0.27	0.67	0.77	0.77
Common Stock Shares Outstanding	0.63	0.58	0.54	0.52	0.5	0.59	0.59	-0.29	0.38	0.3	0.63	0.58	0.3	0.69		0.82	0.46	0.52	0.96	0.84	0.26	0.69	0.17	0.95	0.95	0.28
Non Current Liabilities Total	0.74	0.76	0.56	0.43	0.64	0.67	0.73	0.05	0.49	0.59	0.74	0.49	0.59	0.67	0.82		0.53	0.06	0.89	0.94	0.27	0.88	-0.04	0.83	0.86	0.38
Inventory	0.93	0.87	0.78	0.73	0.94	0.97	0.87	0.55	0.94	0.45	0.93	0.66	0.45	0.94	0.46	0.53		0.07	0.45	0.59	0.92	0.67	0.12	0.42	0.6	0.77
Other Current Assets	0.13	0.14	0.39	0.58	0.03	0.11	0.19	-0.41	0.08	-0.13	0.13	0.58	-0.13	0.29	0.52	0.06	0.07		0.42	0.28	-0.01	0.16	0.69	0.45	0.41	0.3
Other Stockholder Equity	0.63	0.6	0.55	0.5	0.5	0.58	0.6	-0.23	0.41	0.43	0.62	0.57	0.43	0.65	0.96	0.89	0.45	0.42		0.91	0.21	0.81	0.13	0.9	0.96	0.32
Total Liab	0.77	0.82	0.72	0.67	0.65	0.71	0.82	0.05	0.58	0.54	0.77	0.7	0.54	0.76	0.84	0.94	0.59	0.28	0.91		0.32	0.92	0.25	0.84	0.89	0.59
Property Plant And Equipment Gross	0.77	0.67	0.63	0.58	0.8	0.84	0.67	0.56	0.81	0.29	0.76	0.46	0.29	0.78	0.26	0.27	0.92	-0.01	0.21	0.32		0.44	0.05	0.2	0.41	0.63
Total Current Assets	0.83	0.85	0.73	0.63	0.78	0.79	0.79	0.3	0.7	0.78	0.81	0.6	0.78	0.73	0.69	0.88	0.67	0.16	0.81	0.92	0.44		0.1	0.62	0.81	0.68
Short Term Debt	0.1	0.23	0.34	0.67	0.01	0.08	0.32	-0.13	0.12	-0.26	0.11	0.64	-0.26	0.27	0.17	-0.04	0.12	0.69	0.13	0.25	0.05	0.1		0.28	0.17	0.51
Intangible Assets	0.59	0.59	0.5	0.53	0.43	0.53	0.64	-0.31	0.3	0.17	0.6	0.61	0.17	0.67	0.95	0.83	0.42	0.45	0.9	0.84	0.2	0.62	0.28		0.88	0.27
Common Stock Total Equity	0.71	0.68	0.65	0.61	0.58	0.69	0.68	-0.18	0.53	0.41	0.7	0.66	0.41	0.77	0.95	0.86	0.6	0.41	0.96	0.89	0.41	0.81	0.17	0.88		0.4
Short Term Investments	0.78	0.85	0.86	0.89	0.77	0.78	0.84	0.57	0.85	0.48	0.77	0.77	0.48	0.77	0.28	0.38	0.77	0.3	0.32	0.59	0.63	0.68	0.51	0.27	0.4

Click cells to compare fundamentals

Boston Scientific Account Relationship Matchups

Boston Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	30.6B	30.8B	32.2B	32.5B	35.1B	36.9B
Short Long Term Debt Total	10.3B	9.5B	9.5B	9.3B	9.5B	10.0B
Other Current Liab	2.8B	3.0B	3.0B	2.7B	3.2B	3.4B
Total Current Liabilities	4.9B	3.7B	4.3B	3.8B	4.9B	5.2B
Total Stockholder Equity	13.9B	15.3B	16.6B	17.6B	19.3B	20.2B
Property Plant And Equipment Net	2.4B	2.5B	2.7B	2.8B	3.3B	3.5B
Net Debt	10.1B	7.8B	7.5B	8.4B	8.6B	9.1B
Retained Earnings	(2.3B)	(2.4B)	(1.4B)	(750M)	819M	860.0M
Accounts Payable	542M	513M	794M	862M	942M	989.1M
Non Current Assets Total	25.9B	24.1B	25.9B	26.7B	28.6B	30.1B
Non Currrent Assets Other	735M	545M	563M	707M	679M	713.0M
Net Receivables	1.9B	1.5B	1.8B	2.0B	2.2B	2.3B
Common Stock Shares Outstanding	1.4B	1.4B	1.4B	1.4B	1.5B	1.2B
Liabilities And Stockholders Equity	30.6B	30.8B	32.2B	32.5B	34.9B	36.6B
Non Current Liabilities Total	11.8B	11.8B	11.3B	11.1B	10.7B	6.2B
Inventory	1.6B	1.4B	1.6B	1.9B	2.5B	2.6B
Other Current Assets	324M	410M	385M	350M	333M	426.3M
Other Stockholder Equity	15.8B	17.5B	17.7B	18.0B	18.4B	10.0B
Total Liab	16.7B	15.5B	15.6B	14.9B	15.6B	8.6B
Property Plant And Equipment Gross	2.4B	2.5B	2.3B	2.4B	6.8B	7.1B
Total Current Assets	4.7B	6.7B	6.3B	5.8B	6.5B	3.3B
Accumulated Other Comprehensive Income	270M	207M	263M	269M	49M	51.5M
Short Term Debt	1.4B	13M	261M	20M	531M	417.5M
Intangible Assets	7.9B	5.9B	6.1B	5.9B	6.0B	4.9B
Other Liab	3.0B	2.2B	2.1B	1.8B	2.1B	1.9B
Other Assets	(2M)	4.6B	3M	2M	(1M)	950K
Long Term Debt	8.6B	9.1B	8.8B	8.9B	8.6B	5.6B
Good Will	10.2B	10.0B	12.0B	12.9B	14.4B	8.6B
Property Plant Equipment	2.1B	2.1B	2.3B	2.8B	3.3B	1.7B
Current Deferred Revenue	144M	138M	208M	220M	266M	333.1M
Net Tangible Assets	(4.2B)	9.4B	(1.7B)	11.7B	13.4B	14.1B
Retained Earnings Total Equity	(2.3B)	(2.4B)	(1.4B)	(750M)	(862.5M)	(905.6M)
Long Term Debt Total	8.6B	9.1B	8.8B	8.9B	10.3B	6.6B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
GOOG	Alphabet Inc Class C
C	Citigroup

When determining whether Boston Scientific Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Boston Scientific's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Boston Scientific Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Boston Scientific Corp Stock:

How To Invest In Boston

Details

Is Boston Stock a good investment?

Details

What is Boston Scientific's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.

You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Boston Stock analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities

Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.579

Earnings Share

1.19

Revenue Per Share

10.065

Quarterly Revenue Growth

0.138

Return On Assets

0.0454

The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Boston Cost Of Revenue vs Depreciation And Amortization Analysis

Cost Of Revenue vs Depreciation And Amortization

Cost Of Revenue vs Depreciation And Amortization Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Depreciation And Amortization

Boston Scientific fundamental ratios Correlations

Boston Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Boston Scientific fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Boston Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Net	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.97	Total Assets

Other Current Assets	- 0.41	Retained Earnings
Intangible Assets	- 0.31	Retained Earnings
Common Stock Shares Outstanding	- 0.29	Retained Earnings
Short Term Debt	- 0.26	Cash And Short Term Investments
Short Term Debt	- 0.26	Cash
Other Stockholder Equity	- 0.23	Retained Earnings